298 related articles for article (PubMed ID: 35835712)
1. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study.
Byeon SK; Madugundu AK; Garapati K; Ramarajan MG; Saraswat M; Kumar-M P; Hughes T; Shah R; Patnaik MM; Chia N; Ashrafzadeh-Kian S; Yao JD; Pritt BS; Cattaneo R; Salama ME; Zenka RM; Kipp BR; Grebe SKG; Singh RJ; Sadighi Akha AA; Algeciras-Schimnich A; Dasari S; Olson JE; Walsh JR; Venkatakrishnan AJ; Jenkinson G; O'Horo JC; Badley AD; Pandey A
Lancet Digit Health; 2022 Sep; 4(9):e632-e645. PubMed ID: 35835712
[TBL] [Abstract][Full Text] [Related]
2. The Development and Validation of Simplified Machine Learning Algorithms to Predict Prognosis of Hospitalized Patients With COVID-19: Multicenter, Retrospective Study.
He F; Page JH; Weinberg KR; Mishra A
J Med Internet Res; 2022 Jan; 24(1):e31549. PubMed ID: 34951865
[TBL] [Abstract][Full Text] [Related]
3. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units.
Kugler S; Hahnefeld L; Kloka JA; Ginzel S; Nürenberg-Goloub E; Zinn S; Vehreschild MJ; Zacharowski K; Lindau S; Ullrich E; Burmeister J; Kohlhammer J; Schwäble J; Gurke R; Dorochow E; Bennett A; Dauth S; Campe J; Knape T; Laux V; Kannt A; Köhm M; Geisslinger G; Resch E; Behrens F
Talanta; 2024 Feb; 268(Pt 1):125295. PubMed ID: 37866305
[TBL] [Abstract][Full Text] [Related]
4. A new hybrid ensemble machine-learning model for severity risk assessment and post-COVID prediction system.
Shakhovska N; Yakovyna V; Chopyak V
Math Biosci Eng; 2022 Apr; 19(6):6102-6123. PubMed ID: 35603393
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics study of COVID-19 patients in four different clinical stages.
Valdés A; Moreno LO; Rello SR; Orduña A; Bernardo D; Cifuentes A
Sci Rep; 2022 Jan; 12(1):1650. PubMed ID: 35102215
[TBL] [Abstract][Full Text] [Related]
7. Exposing and Overcoming Limitations of Clinical Laboratory Tests in COVID-19 by Adding Immunological Parameters; A Retrospective Cohort Analysis and Pilot Study.
Sánchez-Montalvá A; Álvarez-Sierra D; Martínez-Gallo M; Perurena-Prieto J; Arrese-Muñoz I; Ruiz-Rodríguez JC; Espinosa-Pereiro J; Bosch-Nicolau P; Martínez-Gómez X; Antón A; Martínez-Valle F; Riveiro-Barciela M; Blanco-Grau A; Rodríguez-Frias F; Castellano-Escuder P; Poyatos-Canton E; Bas-Minguet J; Martínez-Cáceres E; Sánchez-Pla A; Zurera-Egea C; Teniente-Serra A; Hernández-González M; Pujol-Borrell R;
Front Immunol; 2022; 13():902837. PubMed ID: 35844497
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features of Emergency Department Patients from Early COVID-19 Pandemic that Predict SARS-CoV-2 Infection: Machine-learning Approach.
Chou EH; Wang CH; Hsieh YL; Namazi B; Wolfshohl J; Bhakta T; Tsai CL; Lien WC; Sankaranarayanan G; Lee CC; Lu TC
West J Emerg Med; 2021 Mar; 22(2):244-251. PubMed ID: 33856307
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Mortality Prediction From Deep Learning in a Large Multistate Electronic Health Record and Laboratory Information System Data Set: Algorithm Development and Validation.
Sankaranarayanan S; Balan J; Walsh JR; Wu Y; Minnich S; Piazza A; Osborne C; Oliver GR; Lesko J; Bates KL; Khezeli K; Block DR; DiGuardo M; Kreuter J; O'Horo JC; Kalantari J; Klee EW; Salama ME; Kipp B; Morice WG; Jenkinson G
J Med Internet Res; 2021 Sep; 23(9):e30157. PubMed ID: 34449401
[TBL] [Abstract][Full Text] [Related]
11. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.
Sindelar M; Stancliffe E; Schwaiger-Haber M; Anbukumar DS; Adkins-Travis K; Goss CW; O'Halloran JA; Mudd PA; Liu WC; Albrecht RA; García-Sastre A; Shriver LP; Patti GJ
Cell Rep Med; 2021 Aug; 2(8):100369. PubMed ID: 34308390
[TBL] [Abstract][Full Text] [Related]
13. Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction.
Lodge S; Lawler NG; Gray N; Masuda R; Nitschke P; Whiley L; Bong SH; Yeap BB; Dwivedi G; Spraul M; Schaefer H; Gil-Redondo R; Embade N; Millet O; Holmes E; Wist J; Nicholson JK
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511373
[TBL] [Abstract][Full Text] [Related]
14. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
Costanzo M; Caterino M; Fedele R; Cevenini A; Pontillo M; Barra L; Ruoppolo M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269564
[TBL] [Abstract][Full Text] [Related]
15. Host transcriptomics and machine learning for secondary bacterial infections in patients with COVID-19: a prospective, observational cohort study.
Carney M; Pelaia TM; Chew T; Teoh S; Phu A; Kim K; Wang Y; Iredell J; Zerbib Y; McLean A; Schughart K; Tang B; Shojaei M; Short KR;
Lancet Microbe; 2024 Mar; 5(3):e272-e281. PubMed ID: 38310908
[TBL] [Abstract][Full Text] [Related]
16. Benchmarking of Machine Learning classifiers on plasma proteomic for COVID-19 severity prediction through interpretable artificial intelligence.
Dimitsaki S; Gavriilidis GI; Dimitriadis VK; Natsiavas P
Artif Intell Med; 2023 Mar; 137():102490. PubMed ID: 36868685
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
19. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives.
Mahmud I; Garrett TJ
J Am Soc Mass Spectrom; 2020 Oct; 31(10):2013-2024. PubMed ID: 32880453
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
